Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205166 · ClinicalTrials.gov registry record · NA
Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00205166 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants.
The verdict
NCT00205166, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
We are studying the affect of caffeine on the sensitivity of detecting coronary artery disease (blockages in the blood flow to the heart) with adenosine tracer scans. Adenosine is a drug used routinely in patients to relax heart blood vessels in order to assess for the presence of coronary artery disease. Often, if patients have had caffeine, the adenosine scan is not used because of the belief that caffeine may reduce the ability to detect coronary artery disease. We would like to test whether caffeine affects our ability to detect coronary artery disease with adenosine tracer scanning. We will perform an imaging study of the heart with adenosine after you have received caffeine.
Interventions
- DRUG Caffeine
- PROCEDURE Cardiac SPECT imaging Rest and Stress
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 1999-06 |
| Est. Completion | 2004-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205166
The ClinicalTrials.gov registry entry for NCT00205166 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Caffeine is the first listed.
NCT00205166 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205166 about?
NCT00205166 is a clinical study titled "Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?". We are studying the affect of caffeine on the sensitivity of detecting coronary artery disease (blockages in the blood flow to the heart) with adenosine tracer scans. Adenosine is a drug used routinely in patients to relax heart blood vessels in order to assess for the presence of coronary artery di...
What is the current status of trial NCT00205166?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 1999-06. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00205166?
The interventions under investigation include: Caffeine (DRUG), Cardiac SPECT imaging Rest and Stress (PROCEDURE).
Who is sponsoring clinical trial NCT00205166?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.